Cancertone Page

×
Useful links
Home Breast Cancer Liver Cancer Colorectal Cancer Prostate Cancer
LifeStyle Bladder Cancer Lung Cancer Gastric cancer Pancreatic Cancer Non-Hodgkin Lymphoma
Cancertone
Tell your Story Tell your loved one story
Socials
YouTube
Facebook
Instagram
Tiktok
Twitter
Telegram
Help & Support
Contact About Us Write for Us

Tamoxifen in Breast Cancer Treatment and Prevention

Category : Breast | Sub Category : Breast Cancer Posted on 2025-07-02 10:41:43


Tamoxifen in Breast Cancer Treatment and Prevention

Tamoxifen in Breast Cancer Treatment and Prevention

Use in High-Risk Patients

Tamoxifen is utilized for the prevention of breast cancer in patients at high risk. The standard treatment duration ranges from 3 to 5 years, with a dosage of 5–20 mg daily, resulting in an approximate 50% reduction in breast cancer risk.

Post-Surgical Treatment for Breast Cancer

Tamoxifen is also employed following breast cancer surgery to reduce the risk of recurrence and metastasis, particularly in estrogen receptor (ER)-positive premenopausal patients. Clinical evidence demonstrates that any duration of tamoxifen therapy is superior to none. Randomized studies indicate the following:

  • One year of tamoxifen is more effective than no treatment.

  • Two years is superior to one year.

  • Five years is more effective than two years, reducing the risk of metastasis by approximately 50%.

For patients with more than three positive lymph nodes, extending tamoxifen treatment to 10 years is more beneficial than 5 years. Additionally, 2–5 years of ovarian suppression further reduces recurrence risk compared to no suppression.

Long-Term Recurrence Risk in ER-Positive Breast Cancer

Studies from Canada, the United Kingdom, and Denmark demonstrate that ER-positive breast cancer carries a prolonged recurrence risk, extending over 20–30 years. Lifestyle interventions, including regular exercise and modest weight reduction, can reduce metastatic risk by approximately 55%. When combined with 5 years of tamoxifen therapy, these measures significantly enhance long-term outcomes and should be considered an integral component of post-operative breast cancer management.

Disclaimer

This information is provided for general informational purposes only and does not constitute professional medical advice. It is not a substitute for consultation with a qualified healthcare provider. For medical emergencies, contact your physician or, in the United States, call 911 immediately.

Leave a Comment:

READ MORE

3 weeks ago Category : Colorectal Cancer
New Discovery Links Mitochondrial DNA to Immunotherapy Success in Cancer Treatment

New Discovery Links Mitochondrial DNA to Immunotherapy Success in Cancer Treatment

Read More →
3 weeks ago Category : Tell us your Story
John’s Journey: Healing Through Lifestyle and Natural Remedies

John’s Journey: Healing Through Lifestyle and Natural Remedies

Read More →
3 weeks ago Category : Tell us your Story
The truth about finding a cure for cancer

The truth about finding a cure for cancer

Read More →
1 month ago Category : Tell us your Story
Federal Government Commissions Three Oncology Centres to Strengthen Cancer Care in Nigeria

Federal Government Commissions Three Oncology Centres to Strengthen Cancer Care in Nigeria

Read More →